NEJM: Modern's vaccine is more effective than Pfizer's

In a new study published yesterday (Wednesday) in the New England Journal of Medicine and reported by the New York Times , a comparison was made “in the real world” between the effectiveness of a company’s vaccine Pfizer compared to that of a modern company. While the two innovative mRNA-based vaccines have been approved for use it has been said that in terms of efficacy they are both equal. But now it turns out from the new study that the data indicate a little differently: there is a difference, even if it is small, in favor of a “modern” vaccine.

Roughly speaking, about 221 million doses of the “Pfizer” vaccine have already been issued For vaccination in the United States, compared to about 150 million of the “Modern” vaccine. About five comparative studies have been published recently, the most recent of which, as stated in “New England”, and the conclusion that emerges from them: Vaccination “Modern” seems to provide greater protection than the Pfizer vaccine months after the injection.

The latest study evaluated efficacy in the “real world” to prevent symptomatic disease among about 5,000 health care professionals And nurses in 25 U.S. states. The effectiveness of the Pfizer vaccine was found to be 88.8%, while that of the Modern is 96.3%. It was also found that the effectiveness of a “modern” vaccine for the prevention of serious illness is in the range of between 92% and 100%, with the Pfizer vaccine lagging behind by about 15% -10%. It was also found that compared to the Delta variant, the “Modern” vaccine is about 30% more effective in prevention.

It was also found that the “Pfizer” vaccine produces one-third to one-half less antibody levels than the one that “Modern” vaccine but the gap is negligible because there are often more than 100 times differences in antibody levels between two healthy people anyway. “Modern” has asked the FDA for approval to give a booster (third dose) at a dose of 50 micrograms – about half the dose of the second dose because the second dose still raises the levels of antibodies in the vaccinated body long after it has been given.

If the gap in efficiency continues to widen, this will also have implications for the debate currently taking place in the US in the context of the booster dose, scientists. Although the difference is not large, it is consistent.

Note: This article has been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Ask The Expert: Gursi Singh & Amrita Khanna thumbnail

Ask The Expert: Gursi Singh & Amrita Khanna

Fashion and style conundrums, deciphered and explained, by designers Gursi Singh & Amrita Khanna This year, I wish to experiment with shiny fabrics and embellishments. Where should I start? Lately, I am really into oversized silk and satin shirts. Be it block silk shirts with top stitch detailing, printed satin shirts, or tie and dye
Read More
Sunshine Private Hospital to roll out Telstra Health's Kyra EMR thumbnail

Sunshine Private Hospital to roll out Telstra Health’s Kyra EMR

Hospital operator Unitas Healthcare is implementing the Kyra Clinical EMR by Telstra Health at the upcoming Sunshine Private Hospital in Melbourne's west. The Kyra EMR provides real-time access to patient information and enables peer-to-peer communication between clinicians, care teams and patients.  WHY IT MATTERS Telstra Health claims that its EMR offering streamlines care delivery, allowing…
Read More
Prescribe fewer antidepressants, and for shorter periods, doctors advised thumbnail

Prescribe fewer antidepressants, and for shorter periods, doctors advised

Credit: Unsplash/CC0 Public Domain Doctors should prescribe fewer antidepressants and for shorter periods of time, because of the ongoing uncertainties about their effectiveness and the potential severity and durability of the withdrawal symptoms associated with them, suggests a review of the evidence on antidepressant use, published online in the Drug and Therapeutics Bulletin. The use…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share